Personalized Ventilator Settings for Patients on ECMO

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of California, San Diego

About this trial

While mechanical ventilation can be used to sustain life in those with lung injury, it, can further worsen lung injury or prevent lung healing resulting in high morbidity and mortality as seen in Acute Respiratory Distress Syndrome (ARDS).

Using extracorporeal membrane oxygenation (ECMO), the highest level of life support also known as the heart-lung machine, investigators may minimize injury from mechanical ventilation to allow the lungs to heal; however, the optimal ventilator strategies while on ECMO are unknown. This study will evaluate personalized ventilator strategy compared to standard of care ventilation.

Eligibility criteria

Qualifiers

History of Lung or Cardiac Transplantation, or definite bridge to transplantation

Patient is not committed to full support

Treating clinician refusal, or unwillingness to commit to controlled therapeutics (Esophageal Pressure Guided Positive End-Expiratory Pressure and neuromuscular blockade)

Inability to get informed consent from the patient or legally authorized representative (LAR)

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Personalized Positive End-Expiratory Pressure (PEEP)

Treatment groups

62 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of California, San Diego

Lead sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator